---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-168329"
form_type: "8-K"
ticker: "SLDB"
cik: "0001707502"
company_name: "Solid Biosciences Inc."
filed_at: "2022-06-06T23:59:59+00:00"
generated_at: "2026-06-25T04:24:35.231552+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Solid Biosciences receives Nasdaq deficiency notice for bid price below $1.00

## Summary
- Received deficiency letter on May 31, 2022 for failing to meet $1.00 minimum bid price requirement over 30 consecutive business days.
- Company has 180 calendar days, until November 28, 2022, to regain compliance by closing at $1.00 or more for 10 consecutive days.
- If not compliant by November 28, may transfer to Nasdaq Capital Market or consider a reverse stock split to cure deficiency.
- There can be no assurance that the Company will be able to regain compliance with the Bid Price Requirement.

## SEC filing metadata
- accession: 0001193125-22-168329
- form_type: 8-K
- ticker: SLDB
- cik: 0001707502
- company_name: Solid Biosciences Inc.
- filed_at: 2022-06-06T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1707502/000119312522168329/0001193125-22-168329-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1707502/000119312522168329/d316587d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-168329
- JSON: https://secwatch.observer/filing/0001193125-22-168329.json
- Plain text: https://secwatch.observer/filing/0001193125-22-168329.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.